belimumab

Known as: Immunoglobulin G1, anti-(Human Cytokine BAFF) (Human Monoclonal LymphoStat-B Heavy Chain), Disulfide with Human Monoclonal LymphoStat-B lambda-chain, Dimer 
A fully human IgG1 monoclonal antibody directed against B-Lymphocyte stimulator protein (BlyS or TNFSF13B) with potential immunomodulating activity… (More)

Topic mentions per year

Topic mentions per year

2005-2017
020406020052017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
The crucial issue for a better pregnancy outcome in women with autoimmune rheumatic diseases is appropriate planning, with… (More)
Is this relevant?
2013
2013
A pooled post-hoc analysis of the phase 3, randomized, placebo-controlled BLISS trials (1684 patients with active systemic lupus… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
OBJECTIVES To identify factors that predict response to belimumab treatment in the phase 3 BLISS trials of autoantibody-positive… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
OBJECTIVE To assess the effects of the B lymphocyte stimulator (BLyS)-specific inhibitor belimumab on immunologic biomarkers… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
OBJECTIVE To evaluate the effects of belimumab versus placebo, plus standard systemic lupus erythematosus (SLE) therapy, on organ… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Systemic lupus erythematosus is a heterogeneous autoimmune disease that is associated with B-cell hyperactivity… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
OBJECTIVE To assess the efficacy/safety of the B lymphocyte stimulator inhibitor belimumab plus standard therapy compared with… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care… (More)
  • table 2
  • table 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
INTRODUCTION This trial evaluated the safety, biologic activity, and pharmacokinetics of belimumab, a fully human monoclonal… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2006
2006
The tolerability, pharmacodynamic effects, and pharmacokinetics of belimumab (LymphoStat-B) were evaluated in cynomolgus monkeys… (More)
Is this relevant?